Member Info for doze

This deleterious behaviour must be the most tedious occurrence of my investing life.

05-Nov-1516:57:061,055.1264170,886Buy* 1,047.001,048.001.803M

today issued and allotted 444,508 ordinary shares http://www.londonstockexchange.com/exchange/news/market-news/market-news-detail/12570472.html

http://www.proactiveinvestors.co.uk/companies/stocktube/4335/new-funds-key-to-vamousse-growth-says-tyratech-chief-exec-4335.html

http://www.londonstockexchange.com/exchange/news/market-news/market-news-detail/12567024.html

http://www.proactiveinvestors.co.uk/companies/news/117048/tyratech-raises-funds-for-vamousse-marketing-drive-117048.html Shares will be placed at 3p per share with £1.2mln of the money earmarked for Vamousse.

Yes, everybody is coming on board. My worry is it is so good at curing, the number of potential treatments will rapidly reduce!

http://uk.reuters.com/article/2015/10/28/europe-markets-idUKL8N12S54R20151028 This article expands on the topic of dependance on Apple

PURRE: SalesMon 14:21 Some may wish to take a capital gain rather than income but taking income now and then selling in the next tax year may utilise a loss position which could be worth doing. It is just drifting down on low volume though and slow dividend payout. I can't see why they need to delay it. ..................... This reply never appeared when posted.

Some may wish to take a capital gain rather than income but taking income now and then selling in the next tax year may utilise a loss position which could be worth doing. It is just drifting down on low volume though and slow dividend payout. I can't see why they need to delay it.

Clear as mud if you read this http://www.lse.co.uk/share-regulatory-news.asp?shareprice=TYRU&ArticleCode=7isrhp22&ArticleHeadline=Migration_of_Shares

Will the sp hold this gain do you think? There seems many macro forces that should keep ARM on a high rating.

I think he has clarified after reading lse! The insurance settlement was for far more than the market cap before the fire. If it gets to 200p it will have more than almost tripled. I was thinking of selling but might be worth waiting for this 200p. It is not that easy to get your head around how a net cash position could rise to $85.2 from $1.5 between two sets of accounts in a business that does not retain much cash. I suppose it lies in the replacement cost of high tech equipment and three years capitalised earnings from Swansea which I believe were the settlement terms for insurance purposes.

a 182p buy at 13.29

3. Full name of person(s) subject to the notification obligation: iii Henderson Global Investors 4. Full name of shareholder(s) (if different from 3.):iv 5. Date of the transaction and date on which the threshold is crossed or reached: v 16 October 2015 6. Date on which issuer notified: 19 October 2015 7. Threshold(s) that is/are crossed or reached: vi, vii Below 19% & 18%

http://www.cambridgenetwork.co.uk/news/pragmatic-secures-major-investment-from-cic-and-arm/

https://www.bio.org/sites/default/files/BIF%202015%20-%20Presenting%20Companies%2010.9.pdf

https://www.bio.org/node/91886 Is he going? Baxalta Ventures are presenting.

per cent of shares issued traded today.

$60.3 profit for discontinued Swansea is a £1.38 payout per share.